November 24, 2020
“Cocrystal Pharma (COCP)… Overall, 2 Buys and no Holds or Sells have been assigned in the last three months. Therefore, the analyst consensus is a Moderate Buy. At $4.75, the average price target puts the upside potential at 452%… DiaMedica… Continue Reading…
November 18, 2020
“Onconova Therapeutics, Inc. (NASDAQ:ONTX) Stock Could Reward Investors With a 1053.85% Gain… The consensus price target for the stock as assigned by Wall Street analysts is $1.83, meaning bulls need an upside of 603.85% from its current market value. According… Continue Reading…
October 21, 2020
“NeuBase Therapeutics (NBSE)… Are other analysts in agreement? They are. Only Buy ratings, 4 to be exact, have been issued in the last three months. Therefore, the message is clear: NBSE is a Strong Buy. Given the $16.50 average price… Continue Reading…
October 20, 2020
“Neos Therapeutics (NEOS)… Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, NEOS has a Strong Buy consensus rating. At $8.33, the average price target… Continue Reading…
October 19, 2020
“Athira Pharma (ATHA)… Judging by the consensus breakdown, opinions are anything but mixed. With 4 Buys and no Holds or Sells assigned in the last three months, the word on the Street is that ATHA is a Strong Buy. At… Continue Reading…
October 18, 2020
“Sunnova Energy International (NOVA) … Are other analysts in agreement? They are. Only Buy ratings, 10 to be exact, have been issued in the last three months. Therefore, the message is clear: NOVA is a Strong Buy. Given the $33.70 average… Continue Reading…
October 16, 2020
“Zynerba Pharmaceuticals (ZYNE)… Turning to the rest of the Street, the bulls have it on this one. With 3 Buys and a lone Hold, the word on the Street is that ZYNE is a Strong Buy. At $13, the average… Continue Reading…
October 13, 2020
“Outlook Therapeutics (OTLK)… Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, OLTK has a Strong Buy consensus rating. With the average price target clocking… Continue Reading…
August 13, 2020
“What happened Coronavirus-related stocks declined sharply on Wednesday, extending their losses following Russia’s announcement on Tuesday that it had developed the world’s first COVID-19 vaccine. As of 11:55 a.m. EDT, shares of Novavax (NASDAQ:NVAX), Heat Biologics (NASDAQ:HTBX), Sorrento Therapeutics (NASDAQ:SRNE), Vaxart (NASDAQ:VXRT), and iBio (NYSEMKT:IBIO) were down 20%, 17%, 15%, 14%,… Continue Reading…
Recent Comments